Hoda Salem | Clinical Trials | Best Researcher Award

Published on by Top Pharmaceutical

Hoda Salem | Clinical Trials | Best Researcher Award

Prof. Dr. Hoda Salem, University of Tabuk, Saudi Arabia

Prof. Dr. Hoda Salem 🎓 is a distinguished clinical pharmacy expert with a Ph.D. in Pharmaceutical Sciences from Tanta University, Egypt 🇪🇬. With over two decades of academic and clinical experience, she currently serves as Professor at Tabuk University, Saudi Arabia 🇸🇦. She has led numerous funded research projects, particularly in neuropharmacology and pharmacogenetics 🧬🧠. A prolific scholar, Dr. Salem has published in Q1 journals 📚 and actively mentors Ph.D. and MSc students. Her contributions extend to curriculum development, hospital training, and quality assurance in education 🌍. She’s a driving force in pharmacy education and clinical research excellence.

Publication Profile

Google Scholar

Education

Prof. Dr. Hoda Salem 🎓 earned her Bachelor’s degree in Pharmaceutical Sciences from Tanta University, Egypt 🇪🇬. She continued her academic journey with a Master’s degree (M.Sc.) in Clinical Pharmacy from the same university, demonstrating early on her commitment to specialized healthcare and pharmaceutical practice 💊. Her pursuit of excellence culminated in a Ph.D. in Clinical Pharmacy in 2008 🧪, also from Tanta University. This strong academic foundation laid the groundwork for her impactful career in clinical pharmacy, education, and research, making her a respected figure in both Egyptian and international pharmaceutical education and clinical advancement.

Experience

Prof. Dr. Hoda Salem ⚕️ has made significant contributions to both scientific and clinical work in pharmacy education and healthcare. She played a pivotal role in quality assurance and accreditation by leading the self-study efforts and contributing to strategic planning at Tabuk and Al-Azhar Universities 📊📚. As a committee member, she helped supervise undergraduate examinations and mentored numerous Ph.D. and M.Sc. research projects 🎓🧬. Her clinical work includes patient counseling, drug dispensing, and providing accurate drug information to healthcare professionals at Tanta University Hospitals 💊🏥, reinforcing her commitment to enhancing both education and patient care.

Research Focus

Prof. Dr. Hoda Salem’s 🧪 research focus lies in clinical pharmacy, pharmaceutics, and neuropharmacology with a multidisciplinary approach integrating nanotechnology, drug delivery systems, and natural compounds. Her publications explore the treatment of diseases such as Alzheimer’s 🧠, Parkinson’s, ADHD, and fungal infections, along with oncology 🧬 and pharmacogenetics in breast cancer therapy. She has also worked on innovative therapies like solid lipid nanoparticles, niosomal gels, and bone marrow stem cell applications. Her clinical trials and lab studies reflect a deep commitment to therapeutic innovation, patient care, and translational research 💊🔬, bridging pharmaceutical science and clinical outcomes for better healthcare.

Publication Top Notes

Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study‏

Neuroprotective effects of phytochemicals against aluminum chloride-induced Alzheimer’s disease through ApoE4/LRP1, wnt3/β-catenin/gsk3β, and TLR4/NLRP3 pathways with physical …‏

Neuroprotective effect of morin hydrate against attention-deficit/hyperactivity disorder (ADHD) induced by MSG and/or protein malnutrition in rat pups: Effect on oxidative …‏

Autologous transplantation of CD34+ bone marrow derived mononuclear cells in management of non-reconstructable critical lower limb ischemia‏

A randomized controlled trial evaluating the effects of amlodipine on myocardial iron deposition in pediatric patients with thalassemia major‏

The role of hepatic expression of STAT1, SOCS3 and PIAS1 in the response of chronic hepatitis C patients to therapy‏

Enhancement of zaleplon oral bioavailability using optimized self-nano emulsifying drug delivery systems and its effect on sleep quality among a sample of psychiatric patients‏

Effective method of evaluating myocardial iron concentration in pediatric patients with thalassemia major‏

Formulation, in-vitro and in-vivo evaluation of nystatin topical gel‏

DEVELOPMENT AND CLINICAL EVALUATION OF TOPICAL HYDROQUINONE NIOSOMAL GEL FORMULATION FOR THE TREATMENT OF MELASMA‏

Effect of oral Methyl Prednisolone on different radiological patterns of hypersensitivity pneumonitis‏

Xinyi Zheng | Pharmacogenomics | Best Researcher Award

Published on by Top Pharmaceutical

Xinyi Zheng | Pharmacogenomics | Best Researcher Award

Ms. Xinyi Zheng Fudan University, China

Ms. Xinyi eis a dedicated researcher in chemical engineering with a strong focus on sustainable polymer science and green catalysis. She has completed over five research projects and contributed 24 articles in SCI-indexed journals. With a citation index of h‑18, Xinyi’s work has attracted wide scholarly attention. She has published 1 book, holds 2 patents, and has contributed to 2 industry-sponsored projects. An editorial board member and an active collaborator internationally, she is also a member of ACS and the Polymer Society of China. Her pioneering innovations make her a strong nominee for the Best Researcher Award 🏆.

Publication Profile 

Orcid

Education

Ms. Xinyi Zheng is a rising star in the field of chemical engineering, specializing in green chemistry and sustainable materials 🌱. She holds a master’s degree in chemical engineering and is currently pursuing her doctoral research with a focus on polymeric catalysts and eco-friendly synthesis methods 🧬. With hands-on experience in academic and industry labs, she has collaborated on cross-disciplinary projects and published widely in high-impact journals 📚. Her work in developing environmentally benign materials has earned recognition for innovation and academic excellence 🏆. Ms. Zheng continues to inspire through her dedication to scientific advancement.

Research and Innovations

Ms. Xinyi Zheng has demonstrated remarkable research excellence through numerous completed and ongoing projects in the fields of green chemistry and sustainable materials 🌱. Her impressive record includes multiple publications in reputed indexed journals 📖, along with innovative patents either published or under process 🔏. With a growing citation index across databases like Scopus and SCI 📊, her work continues to gain global recognition. Additionally, her involvement in consultancy and industry-sponsored projects reflects a strong practical application of her research 💼. Ms. Zheng’s contributions are both impactful and forward-thinking, driving progress in eco-friendly scientific solutions 💡.

Research Focus

Ms. Xinyi Zheng’s research centers on molecular pharmacogenomics, bioinformatics, and precision medicine in oncology and transplantation science 🧪. Her recent work includes analyzing MAPK gene polymorphisms and their roles in renal clear cell carcinoma prognosis and immune response, employing cutting-edge Mendelian randomization and bioinformatic approaches 💻. Additionally, she explores how genetic variations in MAPK pathways affect liver function post-transplant, particularly in patients treated with tacrolimus. Her interdisciplinary focus bridges pharmacology, genomics, and clinical medicine ⚕️—advancing drug response prediction, personalized therapies, and improved transplant outcomes.

Publication Top Notes

Comprehensive analysis of MAPK genes in the prognosis, immune characteristics, and drug treatment of renal clear cell carcinoma using bioinformatic analysis and Mendelian randomization

Donor and recipient polymorphisms of MAPK signaling pathway genes influence post-transplant liver function in Chinese liver transplant patients taking tacrolimus

Asmaa Yehia Ammar | Bioinformatics in Pharmaceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Asmaa Yehia Ammar | Bioinformatics in Pharmaceuticals | Best Researcher Award

Assist. Prof. Dr. Asmaa Yehia Ammar, Animal Health Research Institute, Egypt

Assist. Prof. Dr. Asmaa Yehia Ammar is a dedicated veterinary geneticist with a Ph.D. in Genetics and Genetic Engineering from Alexandria University (2023) 🧬. She also holds an M.D. and B.V.Sc. from Kafrelsheikh University 🐟. Dr. Ammar currently serves as an Assistant Researcher at the Animal Health Research Institute, contributing to pioneering studies on environmental effects on gene expression. Her published work spans reproductive biology and aquaculture genomics 📚. With a Japan-based research scholarship (2021), strong teamwork 🤝, and leadership skills ⭐, she stands out as a rising star in veterinary molecular genetics and environmental genomics.

Publication Profile 

Orcid

Education

Assist. Prof. Dr. Asmaa Yehia Ammar has built a solid academic foundation in veterinary genetics. She earned her Ph.D. in Genetics and Genetic Engineering (2018–2023) from the Faculty of Veterinary Medicine at Alexandria University 🧬. Prior to that, she completed her M.D. in the same field (2014–2017) at Kafrelsheikh University 🧪. Her academic journey began with a Bachelor’s degree in Veterinary Medicine (2003–2008) from Kafrelsheikh University 🐾. This progressive educational path reflects her deep commitment to advancing veterinary science and genetic research, forming the core of her expertise and innovative contributions to animal health and biotechnology 🌿.

Awards

Assist. Prof. Dr. Asmaa Yehia Ammar was awarded a prestigious one-year joint supervision scholarship in Japan 🎓🇯🇵. This international academic opportunity allowed her to collaborate with leading researchers and institutions in the field of genetics and genetic engineering 🧬. The experience enriched her scientific perspective, enhanced her laboratory skills, and exposed her to advanced research methodologies 🔬. It also fostered cross-cultural academic exchange, contributing to her growth as a globally engaged scientist 🌐. This scholarship marks a significant milestone in her academic journey, reinforcing her dedication to excellence and innovation in veterinary and genetic research.

Research Focus

Assist. Prof. Dr. Asmaa Yehia Ammar specializes in genetics and genetic engineering 🧬, with a strong research focus on environmental stressors and gene expression in animal reproduction and aquatic species 🐟🧫. Her studies explore how factors like low-oxygen environments, thermal stress, and climate variation influence reproductive function, immune responses, and molecular gene regulation in organisms like mice and Nile tilapia 🐭🌡️. Her work bridges molecular biology, veterinary science, and environmental physiology, contributing to advances in animal health, biotechnology, and reproductive genetics 🌍📈. Her research is vital for climate-resilient livestock and aquatic health strategies.

Publication Top Notes

Ammar, A. Y., Minisy, F. M., Shawki, H. H., Mansour, M., Hemeda, S. A., El Nahas, A. F., … & Oishi, H. (2024). Exposure to a Low-Oxygen Environment Causes Implantation Failure and Transcriptomic Shifts in Mouse Uteruses and Ovaries. Biomedicines, 12(5), 1016.

Ammar, A. Y., El Nahas, A. F., Mahmoud, S., Barakat, M. E., & Hassan, A. M. (2018). Characterization of type IV antifreeze gene in Nile tilapia (Oreochromis niloticus) and influence of cold and hot weather on its expression and some immune-related genes. Fish physiology and biochemistry, 44, 515-525.

Hassan, A. M., El Nahas, A. F., Mahmoud, S., Barakat, M. E., & Ammar, A. Y. (2017).　Thermal stress of ambient temperature modulate expression of stress and immune-related　genes and DNA fragmentation in Nile tilapia (Oreochromis niloticus (Linnaeus,　1758)). Appl. Ecol. Environ. Res, 15(3), 1343-1354.

Elbialy, Z. I., El-Nahas, A. F., Elkatatny, N. A., & Ammar, A. Y. (2016). Quantitative　expression analysis of myostatin gene in Nile Tilapia (Oreochromis niloticus) tissues in　adult stage. Alexandria Journal of Veterinary Sciences, 51(1), 170-173

Hongwei Yao | Gastrointestinal Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Hongwei Yao | Gastrointestinal Pharmacology | Best Researcher Award

Prof. Hongwei Yao, capital medical university Affiliated Beijing Friendship Hospital, China

Prof. Dr. Hongwei Yao 🧑‍⚕️ is a renowned gastrointestinal surgeon with over 20 years of experience in diagnosing and treating GI tumors. 💉 He excels in laparoscopic and transanal endoscopic microsurgery (TEM) 🩺 and has led multiple research studies, authoring 100+ academic papers 📚—90+ focused on colorectal surgery. 🧬 He is the lead translator of Standard Laparoscopic Surgery for Upper GI Tract and co-translator of the national textbook Colorectal and Anal Surgery. 🔬 Prof. Yao holds two utility model patents for surgical innovations and continues to pioneer breakthroughs in colorectal cancer treatment. 🧠 His work bridges clinical expertise and cutting-edge research.

Publication Profile 

Orcid

Education

Prof. Dr. Hongwei Yao 🧑‍⚕️ is a distinguished gastrointestinal surgeon with over 20 years of clinical excellence in diagnosing and treating GI tumors 🧬. An expert in advanced surgical techniques such as laparoscopic surgery and transanal endoscopic microsurgery (TEM) 🔍, he is known for handling complex gastrointestinal procedures with precision. He has led numerous research projects and authored more than 100 academic papers 📚, with over 90 focusing on colorectal surgery. He served as lead translator of Standard Laparoscopic Surgery for Upper GI Tract 📘 and co-translator of Colorectal and Anal Surgery 📖. Prof. Yao also holds two utility model patents .

Editorial Appointments

Prof. Hongwei Yao 🧑‍⚕️ holds esteemed editorial roles in several leading medical journals. Since December 2019, he has served as Associate Editor for the Diseases of the Colon & Rectum journal 🧻, which is indexed in SSCI. Additionally, he has been a dedicated Editorial Board Member for the Chinese Journal of Inflammatory Bowel Diseases 💢 since February 2017, and for the Chinese Journal of Digestive Surgery 🩺 since July 2021, both indexed in CSCD and CSTPCD. These appointments reflect his profound expertise in gastrointestinal surgery and commitment to advancing medical research and literature 📚.

Research Focus

Prof. Hongwei Yao 🧑‍⚕️ focuses his groundbreaking research on colorectal cancer, gastrointestinal surgery, and translational oncology 🧬. His core interest lies in neoadjuvant therapies combining chemoradiation with immunotherapy (especially PD-1/PD-L1 blockade) for treating locally advanced rectal cancer 🎯. His innovative studies explore gut microbiota, nanomedicine, biospectroscopy, and surgical optimization to personalize cancer care 🧪. He also advances wound healing and stem cell therapies for post-surgical recovery 🩹. Through high-impact publications and clinical trials, Prof. Yao contributes to redefining standards in cancer diagnostics, surgical margins, and immune modulation in GI tumors ⚕️.

Publication Top Notes

Neoadjuvant chemoradiation with or without PD-1 blockade in locally advanced rectal cancer: a randomized phase 2 trial

Opportunities and challenges of indocyanine green in gastrointestinal cancers for intraoperative and nano-medicine application

Opportunities and challenges of nanomaterials in wound healing: Advances, mechanisms, and perspectives

Enhancing thromboprophylaxis after colorectal cancer surgery in China: Bridging the gap between evidence and implementation through pathway optimization

Exploring causal correlations between circulating levels of cytokines and colorectal cancer risk: A Mendelian randomization analysis

Gut microbiome model predicts response to neoadjuvant immunotherapy plus chemoradiotherapy in rectal cancer

Definition and grading of anastomotic leakage following right hemicolectomy

Perfusion outcomes with near-infrared indocyanine green imaging system in laparoscopic total mesorectal excision for mid-rectal or low-rectal cancer (POSTER): a study protocol

The Role and Prospects of Mesenchymal Stem Cells in Skin Repair and Regeneration

Josep Allué Creus | Regulatory Affairs | Best Researcher Award

Published on by Top Pharmaceutical

Josep Allué Creus | Regulatory Affairs | Best Researcher Award

Prof. Dr. Josep Allué Creus, Apdena Consult, Spain

Prof. Dr. Josep Allué Creus 🧪🌿 is a renowned Doctor of Pharmacy and expert in phytotherapy. A retired Professor of Plant Physiology at the Universitat Autònoma de Barcelona 🎓, he co-directs the Master’s and Postgraduate Programs in Phytotherapy at IL3, University of Barcelona 💻📘. He serves as the spokesperson for Medicinal Plants and Homeopathy at the College of Pharmacists of Barcelona 💊 and is a founding member and treasurer of SEFIT. As part of AEEM’s Natural Products group 👩‍⚕️, his research integrates botanical science and women’s health, making him a leader in herbal medicine 🌸🔬.

Publication Profile

Orcid

Education

Prof. Dr. Josep Allué Creus 🎓🧪 exemplifies academic excellence with a prestigious Doctorate in Pharmacy, laying the cornerstone for his remarkable contributions to the fields of phytotherapy and medicinal plant sciences 🌿📚. His doctoral foundation reflects a deep-rooted dedication to advancing healthcare through botanical knowledge and evidence-based research 🔬💊. Prof. Allué’s commitment to scientific integrity and innovation has positioned him as a respected authority in natural medicine 🌱, influencing both academic circles and clinical applications. His passion for teaching and research continues to inspire the next generation of pharmacists and phytotherapy experts across Spain and beyond 🌍👨‍🏫.

Experience

Prof. Dr. Josep Allué Creus 📘🌿 has made significant academic and teaching contributions as a Professor of Plant Physiology at the Universitat Autònoma de Barcelona 🏛️. Throughout his career, he nurtured and mentored countless students, shaping future generations of scientists, pharmacists, and healthcare professionals 👩‍⚕️🧑‍🔬. His passion for education did not end with retirement—he continues to share his expertise as a co-director of master’s and postgraduate programs in phytotherapy through IL3 at the University of Barcelona 🎓🌱. Prof. Allué’s unwavering dedication to lifelong learning and botanical sciences remains a beacon of inspiration in academic circles 🔬📖.

Research Focus

Prof. Dr. Josep Allué Creus 🧠🌿 focuses on two dynamic research domains: phytotherapy and neurodegenerative diseases. His pioneering work on medicinal plant extracts 🌱, such as hemp-derived compounds, highlights their therapeutic potential for conditions like gastrointestinal disorders and dyspepsia 💊. Parallelly, he contributes extensively to cutting-edge Alzheimer’s research, especially in biomarker development for early detection of cognitive decline 🧬🧪. His publications delve into plasma-based assays for amyloid and tau proteins, advancing non-invasive diagnostics in neurology 🧫🔍. Bridging natural medicine and modern neurobiology, Prof. Allué champions holistic innovation in health science.

Publication Top Notes

Hemp Extract (<i>Extractum Cannabis</i>) in the Treatment of Gastrointestinal Distress and Dyspepsia: Historical Insights from Barcelona, Spain

Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer’s disease in individuals with subjective cognitive decline

Clinical utility of an antibody-free LC-MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study

Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity

Detecting amyloid positivity in early Alzheimer’s disease using combinations of plasma Aβ42/Aβ40 and p-tau

Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease

Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations

Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort

The global Alzheimer’s Association round robin study on plasma amyloid β methods

Plasma amyloid, phosphorylated tau, and neurofilament light for individualized risk prediction in mild cognitive impairment

Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer’s Disease

Laura Weinstein | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Laura Weinstein | Drug Delivery Systems | Best Researcher Award

Ms. Laura Weinstein, University of Delaware, United States

Ms. Laura Weinstein is an accomplished biomedical engineering student at the University of Delaware 🎓, set to graduate in May 2025 with a stellar GPA of 3.97. With minors in nanoscale materials and chemistry 🧪, she has led impactful research in nanoparticle drug delivery, orthotic device innovation, and immunoengineering. Her work spans labs at Delaware and Vanderbilt 🏥, earning her top honors including the Eugene du Pont Memorial Scholarship and Best Poster Awards 🏆. Passionate about translational medicine, Laura’s dedication to improving healthcare through engineering solutions marks her as a rising star in biomedical research 🌟.

Publication Profile 

Google Scholar

Education

Ms. Laura Weinstein is currently pursuing an Honors Bachelor of Science in Biomedical Engineering at the University of Delaware, with expected graduation in May 2025 📅. She maintains an outstanding GPA of 3.97 🌟 and complements her major with minors in Nanoscale Materials and Chemistry ⚗️. Her coursework spans core sciences and advanced engineering, including Introductory Biology 🧬, General Chemistry 🧪, Physics ⚛️, and Biomedical Experimental Design 📊. She has also delved into Immunoengineering, Cell Engineering 🧫, Nanomaterials, and Nanomedicine 💉. Proficient in Python and MATLAB 💻, Laura combines technical skills with scientific curiosity, preparing her for groundbreaking biomedical research 🔬.

Awards

Ms. Laura Weinstein has received numerous prestigious honors throughout her academic journey. From 2021–2025, she was awarded the esteemed Eugene du Pont Memorial Scholarship 🎓, covering full tuition, housing, meals, and book expenses. In 2024, she earned 1st place for designing a prototype to secure thoracostomy tubes 🩺. She is also a National Cyber Scholar (2022–2024) 💻 and won the Biomedical Engineering Distinguished Sophomore Award in 2023 🧬. That same year, she was recognized by the Delaware Department of Technology and Information 📡. In 2022, she placed 1st in the Ratcliffe Eco Entrepreneurship Innovation Sprint 🌱🚀

Experience

Ms. Laura Weinstein has been actively engaged in cutting-edge research at the University of Delaware’s Day Lab since January 2022 🏛️. Under the mentorship of Dr. Emily Day and PhD candidate Eric Sterin 👩‍🏫, she developed polymeric nanoparticles for biomimetic cargo delivery via cancer cell membranes 🧫. She contributed to refining purification protocols for DiD-fluorescent nanoparticles 💡 and guided fellow undergraduates in research techniques 📘. Her dedication extended beyond semesters, participating in multiple research fellowships and programs including the 2022 CBER Summer Scholars REU, 2023 Winter Fellowship, and 2024–2025 Summer/Winter Fellowships 🧪📊—highlighting her passion for biomedical innovation.

Research Focus

Ms. Laura Weinstein focuses her research in the dynamic field of biomedical nanotechnology and targeted drug delivery 🧪. Her studies explore cell biomimicry, using cancer cell membranes to improve therapeutic delivery for hematological cancers 🧫🩸. She also investigates nanoparticle purification challenges, ensuring enhanced precision in drug transport systems 🎯. Her work integrates principles of nanomedicine, immunoengineering, and materials science to develop innovative approaches in cancer treatment and diagnostics 🧬. Through her publications and lab experience, Laura contributes to advancing next-generation polymeric nanoparticle technologies—blending engineering and biology to revolutionize patient care and medical outcomes 🚀💊.

Publication Top Notes

Hiding in Plain Sight: Cell Biomimicry for Improving Hematological Cancer Outcomes

Standard purification methods are not sufficient to remove micellular lipophilic dye from polymer nanoparticle solution

Golgem Mehmetoglu | Clinical Trials | Best Researcher Award

Published on by Top Pharmaceutical

Golgem Mehmetoglu | Clinical Trials | Best Researcher Award

Ms. Golgem Mehmetoglu, European University of Lefke, Cyprus

Ms. Gölgem Mehmetoğlu is a dedicated physiotherapist and academic specializing in Physiotherapy and Rehabilitation. 🎓 She earned her B.Sc. from Eastern Mediterranean University (2011–2015), her M.Sc. from European University of Lefke (2015–2017), and is currently pursuing her Ph.D. at EMU. 🧠 Her research focuses on muscle function, postural stability, and rehabilitation outcomes, with multiple publications in international journals and conference proceedings. 📝 She also teaches core courses such as Kinesiology, Biomechanics, and Manual Therapy Techniques. 👩‍🏫 Her scientific contributions and educational roles make her a valuable candidate for the Best Researcher Award.

Publication Profile

Orcid

Education

Ms. Gölgem Mehmetoğlu is a passionate professional in the field of Physiotherapy and Rehabilitation 🧘‍♀️. She completed her undergraduate studies (2011–2015) at Doğu Akdeniz University 🏛️, laying a strong foundation in clinical practice and patient care. She then pursued her Master’s degree (2015–2017) at Lefke Avrupa University 📘, deepening her knowledge in rehabilitation science. Currently, she is advancing her academic journey through a Ph.D. program at Doğu Akdeniz University (2018–present) 🧪. Her academic path reflects commitment to continuous learning and specialization in physiotherapy, contributing to healthcare with evidence-based practice and innovative research.

Academic Positions

Ms. Golgem Mehmetoğlu 🎓 is a dedicated academic in the field of physiotherapy and rehabilitation, actively engaged in teaching at the undergraduate level. She shares her expertise through a variety of core courses including Kinesiology 🤸‍♀️, Biomechanics 🦴, Normal Motor Development 🧠, and Manual Therapy Techniques (Manipulation-Mobilization I & II) 💆‍♀️. Her teaching approach combines theoretical knowledge with hands-on application, empowering students with essential clinical and analytical skills. Through her passionate involvement in education, Ms. Mehmetoğlu continues to inspire future healthcare professionals and contribute meaningfully to the advancement of physiotherapy science.

Research Focus

Ms. Gölgem Mehmetoğlu’s 🔬 research primarily focuses on musculoskeletal rehabilitation, particularly addressing chronic pain, posture correction, functional mobility, and manual therapy in physiotherapy patients. Her studies emphasize the impact of stabilization exercises 🧘‍♀️ on pain relief, posture (craniovertebral angle 📐), disability reduction, and quality of life 🌿 in conditions like chronic neck pain and lateral epicondylitis. Her work explores the integration of exercise science, biomechanics 🤸, and evidence-based physiotherapy to improve patient outcomes. Through randomized controlled trials and clinical interventions, she contributes valuable knowledge to rehabilitation sciences and therapeutic exercise interventions.

Publication Top Notes

Effect of Postural Stabilization Exercises in Combination with Cervical Stabilization Exercises on Craniovertebral Angle, Pain, Disability, and Quality of Life in Patients with Chronic Neck Pain: A Randomized Controlled Trial

The Effects of Muscle Strength and Muscle Endurance on Upper Extremity Functions of Lateral Epicondylitis Patients

The Pain in the Canon of Medicine: Types, Causes, and Treatment

Shobha Singh | Pharmaceutical Chemistry | Pharmaceutical Excellence Award

Published on by Top Pharmaceutical

Shobha Singh | Pharmaceutical Chemistry | Pharmaceutical Excellence Award

Prof. Dr. Shobha Singh, Hygia Institute of Pharmaceutical Education and Research, Lucknow, India

Prof. Dr. Shobha Singh is a distinguished academic and researcher in pharmaceutical sciences, currently serving at Hygia Institute of Pharmaceutical Sciences, Lucknow 🏫. With a Ph.D. from AcSIR–CSIR-NBRI (2022) and a specialization in Pharmaceutical Chemistry 💊, she brings over a decade of teaching and 6 years of research experience. Her expertise spans synthetic organic chemistry, phytochemistry, and heterocyclic compound synthesis 🔬. A member of IPGA and the Society of Ethnopharmacology 🌱, she has guided numerous M. Pharm. theses and contributed to international conferences. Her passion and innovation continue to drive excellence in drug research and development.

Publication Profile

Orcid

Education

Prof. Dr. Shobha Singh has pursued a strong academic path in the field of pharmaceutical sciences 📚. She earned her Ph.D. from AcSIR, CSIR-NBRI, Lucknow, with a CGPA of 7.42 🧪. She completed her M. Pharm. in Pharmaceutical Chemistry from Uttar Pradesh Technical University in 2008 with an impressive 80.30% 🧬. Her B. Pharm. was accomplished at Northern India Engineering College in 2006 with 65.83% 📖. Prior to that, she excelled in her Intermediate (1999) and High School (1997) from U.P. Board with 70% marks in both 🎯—showcasing a consistent academic record 📈.

Experience

Prof. Dr. Shobha Singh brings over a decade of valuable teaching experience in pharmaceutical sciences 🎓. She began her academic journey as a Lecturer at the Rameshwaram Institute of Technology and Management, Lucknow, from July 23, 2008, to April 2011 🏫. She then served as an Assistant Professor at Sherwood College of Pharmacy, Barabanki, from August 16, 2011, to January 16, 2014 🧪. Currently, she continues to educate and guide M. Pharm. students specializing in Pharmaceutical Chemistry 💊—inspiring future researchers and professionals with her deep subject expertise and mentorship 🌟.

Awards

Prof. Dr. Shobha Singh has marked her journey with notable academic and professional achievements 🏆. She holds a prestigious lifetime membership with the Indian Pharmacy Graduates’ Association (I.P.G.A.) 🧬 and is also a proud member of the Society of Ethnopharmacology 🌿, reflecting her commitment to advancing traditional and modern pharmaceutical sciences. Her academic excellence is further highlighted by qualifying the GATE examination twice, in 2006 and 2009 🎓, and the GPAT examination in 2013 📘. These accolades not only signify her academic rigor but also her dedication to continuous professional growth and research excellence 📈.

Research Focus

Prof. Dr. Shobha Singh’s research focus lies at the intersection of phytochemistry, pharmaceutical chemistry, and natural product pharmacology 🌿🧪. She specializes in the phytochemical investigation and biological evaluation of medicinal plants such as Ajuga parviflora, Sesbania sesban, and Sesbania grandiflora 🌸. Her work spans the synthesis of novel heterocyclic compounds, antioxidant activity, and in silico and in vivo pharmacological screening, particularly for anticonvulsant and anticancer properties 🧬💥. She integrates traditional knowledge with modern techniques like molecular docking, enhancing drug discovery from natural sources 🔍🌍. Her research supports innovation in plant-based drug development.

Publication Top Notes

Phytochemical and pharmacological evaluation of Ajuga parviflora Benth

Synthesis and in silico and in vivo anticonvulsant activities of substituted 2-phenyl indole derivatives

Phytochemical investigation and in-vitro antioxidant activity of Sesbania sesban and Sesbania grandiflora seeds

Sudeep Nagaraj | Immunotherapy | Best Researcher Award

Published on by Top Pharmaceutical

Sudeep Nagaraj | Immunotherapy | Best Researcher Award

Dr. Sudeep Nagaraj, ICAR-NIVEDI, India

Dr. Sudeep Nagaraj is an accomplished molecular biologist and research scientist with a Ph.D. from GITAM University (2025) 🎓. He possesses extensive hands-on expertise in molecular genetics, cytogenetics, proteomics, virology, and phytochemistry 🧪🌿. With over six years of academic and research experience, he has served in various prestigious institutions including ICAR-NIVEDI and ICAR-IVRI 🏛️. Dr. Nagaraj has authored 20+ peer-reviewed publications on cytotoxicity, DNA barcoding, and viral epidemiology 📚. His primary research focus lies in virology and molecular diagnostics, especially lumpy skin disease in livestock 🐄🦠. He is known for blending academic rigor with applied research for public health impact 💡.

Publication Profile

Google Scholar

Education

Dr. Sudeep Nagaraj holds a Ph.D. in Molecular Biology from GITAM University (2025) 🧬, an MSc from SDUAHER, Tamaka Kolar (2016) 🧪, and a BSc from FGC, KGF (2012) 📚. His academic journey began at Chinmaya Vidyalaya, Kolar (SSLC, 2007) and continued through BGS PU College (PUC, 2009) 🏫. Professionally, he has accumulated diverse experience across esteemed research institutions and labs, contributing significantly to molecular and virology research 🧫. Additionally, he has one year of teaching experience in Molecular Biology at SIMS and RC, where he taught undergraduate students with dedication and clarity 🎓🧑‍🏫.

Experience

oDr. Sudeep Nagaraj has amassed rich experience through roles such as SRF at ICAR-NIVEDI (2021–present) 🧬, Young Professional-II at ICAR-IVRI (2020–2021) 🧫, and Research Scientist at Cytogene Diagnostics (2019–2020) 🔬. His journey also includes positions at SIMS and RC, QTLomics, and IDBR. He taught Molecular Biology at SIMS and RC for a year at the UG level 🎓. His hands-on skills span molecular genetics (PCR, DNA isolation, HRM), proteomics (SDS-PAGE, Bradford assay), cytogenetics (karyotyping), gene cloning, cell culture, virology (ELISA, virus titration), and phytochemistry (plant extract prep) 🧬🌿🧫.

Awards

Dr. Sudeep Nagaraj has been honored with several prestigious awards for his outstanding contributions to scientific research and innovation 🧠🔬. He received the Young Scientist Award at the International Conference on Science, Health, and Engineering held in Chennai on January 11, 2020 🏆. In 2021, he was conferred the Best Researcher Award at the International Research Awards on New Science Inventions on August 11 in Chennai 🥇. Most recently, in 2025, he was recognized once again with a Young Scientist Award from Scientific Laurels, celebrating his continued excellence in research 🚀📚.

Research Focus

Dr. Sudeep Nagaraj’s research centers around molecular virology, cytogenetics, and immunology, with a significant emphasis on Lumpy Skin Disease (LSD) in livestock 🐄. His work extends to plant-based cytotoxicity, DNA barcoding, and cell culture techniques, reflecting a strong interdisciplinary foundation 🌿🧪. His studies explore pathogen-host interactions, viral evolution, and molecular diagnostics, contributing vital insights into disease spillovers and viral epidemiology across species 🧠🔍. He also focuses on PBMC assays, ELISA, and nanoparticle toxicity, bridging biomedicine, virology, and phytochemistry. His impactful contributions aid in zoonotic disease management and therapeutic development 📊💉🌾.

Publication Top Notes

Lumpy Skin Disease (LSD) in Yak (Bos grunniens): An Evidence of Species Spillover from Cattle in India

Evaluation of In Vitro Cytotoxic Effects of Three Medicinal Plants on Peripheral Blood Mononuclear Cells (PBMC)

First evidence of lumpy skin disease in mithun (Bos frontalis) in India

An in vitro cytotoxic and genotoxic properties of Allamanda cathartica L. Latex green NPs on human peripheral blood mononuclear cells

Unravelling the genomic origins of lumpy skin disease virus in recent outbreaks

Evaluation of HCP5 and Chemokine C receptor type 5 gene polymorphisms in Indian psoriatic patients

DNA based identification of species of Zingiberaceae family plants using Bar-Hrm analysis

A SIMPLE, COST­EFFECTIVE, FAST AND EASY TO ISOLATE DNA PROTOCOL FROM HUMAN SAMPLES

Investigation of Comorbidity and Risk Analysis During Lumpy Skin Disease Outbreaks in India

Evaluation of invitro cytotoxic activity of parts of Murraya koenigii (curry) plant on human peripheral blood mononuclear cells

Separation and Optimisation of a Sucrose Density Gradient Centrifugation Protocol for Isolation of Peripheral Blood Mononuclear Cells (PBMC)

Fast and Easy Protocol of DNA Extraction from Fresh and Hard/Dried Plant Samples of Indian Spices

Nan Jiang | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Nan Jiang | Nanomedicine | Best Researcher Award

Dr. Nan Jiang, Peking University School and Hospital of Stomatology, China

Dr. Nan Jiang is a distinguished biomedical researcher with a Ph.D. from Peking University (2015) and training from Columbia University and NYU School of Medicine. 🧠🦷 Her pioneering research focuses on craniofacial development, aging, and regeneration, especially through nanomedicine and exosome technologies. 🚀🧪 She has published over 35 peer-reviewed articles and authored a book on stem cells in craniofacial regeneration 📘. With an H-index of 16 📊 and a U.S. patent on exosome-based diagnostics, Dr. Jiang is shaping the future of regenerative dentistry and tissue engineering. 🌟🧫 Her innovative work continues to impact both science and clinical practice.

Publication Profile

Scopus

Education

Dr. Nan Jiang earned her Ph.D. in 2015 from Peking University 🎓, enriched by joint training at Columbia University 🇺🇸 and a visiting scholarship at NYU School of Medicine in 2017 🏥. Her research journey is rooted in the developmental biology of craniofacial organs, exploring mechanisms of aging and regeneration 🦷⏳. She is a pioneer in unveiling how nanomedicine can modulate the bone microenvironment 🔍💊. Through interdisciplinary approaches combining stem cell science, exosomes, and tissue engineering, Dr. Jiang continues to contribute groundbreaking insights to regenerative medicine and biomedical innovation.

Professional Memberships

Dr. Nan Jiang is an active member of the International Association for Dental Research (IADR) 🌍🦷, a globally respected organization that fosters excellence in oral health research. Through her membership, she collaborates with a diverse network of scientists and clinicians, advancing the frontiers of dental and craniofacial research 🔬🤝. Her involvement in IADR provides her with valuable opportunities to share her innovative work on nanomedicine, exosomes, and tissue regeneration at international forums 🌐📢. This professional affiliation strengthens her mission to translate scientific discoveries into real-world therapeutic solutions for oral health and beyond 🧪💡.

Research Focus

Dr. Nan Jiang’s research focus lies at the intersection of regenerative medicine, craniofacial biology, and nanotechnology 🧬🧫. She is particularly recognized for her work in regenerative endodontics, leveraging exosomes, stem cells, and nanomedicine to repair and regenerate dental tissues such as the pulp-dentin complex 🦷💉. Her studies also explore osteogenesis, oral tissue aging, and bone microenvironment modulation, with a special interest in single-cell RNA sequencing for understanding tooth development at a molecular level 🧠🔍. Her multidisciplinary approach is redefining future clinical practices in oral and maxillofacial regenerative therapies 🚀🏥.

Publication Top Notes

Regenerative endodontic therapy: From laboratory bench to clinical practice

Correction: Exosomes derived from human exfoliated deciduous teeth ameliorate adult bone loss in mice through promoting osteogenesis (Journal of Molecular Histology, (2020), 51, 4, (455-466), 10.1007/s10735-020-09896-3)

Advances in tooth development studies based on single-cell RNA sequencing